Bank of America
ARNA

Bank of America’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bank of America’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-54,000
Closed -$2.35M – 7559
2018
Q2 		$2.35M Sell
54,000
-4,100
-7% -$176K ﹤0.01% 3851
2018
Q1 		$2.29M Buy
+58,100
New +$2.26M ﹤0.01% 3776
2015
Q1 		– Sell
-1,620
Closed -$56K – 7725
2014
Q4 		$56K Sell
1,620
-410
-20% -$16.6K ﹤0.01% 6276
2014
Q3 		$85K Sell
2,030
-3,560
-64% -$159K ﹤0.01% 6135
2014
Q2 		$328K Sell
5,590
-10,200
-65% -$642K ﹤0.01% 5039
2014
Q1 		$995K Sell
15,790
-450
-3% -$29.9K ﹤0.01% 3912
2013
Q4 		$950K Sell
16,240
-19,240
-54% -$1.01M ﹤0.01% 4110
2013
Q3 		$1.87M Buy
35,480
+13,120
+59% +$881K ﹤0.01% 3337
2013
Q2 		$1.72M Buy
+22,360
New +$1.83M ﹤0.01% 3397

Bank of America's ARNA Position: Q1 2022 in Review

Bank of America sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 115,252 shares — an estimated $10.7M sold.

Bank of America first reported a position in ARNA in Q2 2013 and held it in 35 quarters. The position peaked at $11.1M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Bank of America reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Bank of America sold 115,252 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $10.7M.
  • Bank of America first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
  • Bank of America's Arena Pharmaceuticals Inc position peaked at $11.1M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Bank of America's 13F filing for Q1 2022, filed 16 May 2022.